Optimization of Overseas Manufacturing Sites and Transfer of Production Functions
First written in FY2016. 1 of 3 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2017.
13 other companies' latest entry also says "Restated".
- FY2017RestatedAnnual report
「In the overseas tobacco business, we made capital investments of ¥68.4 billion, primarily in investments associated with optimizing manufacturing sites, in addition to improving product specifications and other measures.」
In the overseas tobacco business, ¥68.4 billion was invested in facilities in connection with the optimization of manufacturing sites. - FY2017-Q2AdvancedAnnual report
「This was due to the decline in domestic sales volumes of cigarettes, as well as the transfer of manufacturing for some cigarettes intended for export to overseas factories.」
Manufacturing for some cigarettes intended for export was transferred from domestic factories to overseas factories. - FY2016First statedAnnual report
「Going forward, we plan to close the Lisnafill factory in Northern Ireland and the Wellvik factory in Belgium, discontinue the MYO product manufacturing lines at the Trier factory in Germany, and transfer the manufacturing functions at these factories to factories in Poland and Romania.」
The company plans to close European factories and discontinue manufacturing lines, transfer manufacturing functions to Poland and Romania, and stated that consultations with employees and labor unions had been completed.